Kerr Holbrook - Mar 5, 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Commercial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Stock symbol
AVNS
Transactions as of
Mar 5, 2024
Transactions value $
-$28,178
Form type
4
Date filed
3/6/2024, 04:09 PM
Previous filing
May 9, 2023
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability -$28.2K -1.5K -2.79% $18.76 52.3K Mar 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) awarded to the Reporting Person on March 4, 2022, of which 1/3 vested on March 4, 2023, 1/3 vested on March 4, 2024 and the remaining 1/3 will vest on March 4, 2025.